Peggy Sanborn, Dignity Health's VP for strategic growth and diversified services, outlines the geographical challenges of health system expansion.
Most patients need little or no opioid pain medication after a postsurgical discharge, according to new research.
The Trump administration's proposed public charge rule could affect the health status of 350,000 patients at the country's largest public hospital.
FierceHealthcare recently spoke with Civica Rx CEO Martin VanTrieste about the days ahead.
Healthcare spending slowed for the second consecutive year, largely due to lower utilization of services.
The Department of Health and Human Services has named a new adviser to oversee its drug pricing initiatives.
New reports from two top rating agencies offer a gloomy outlook for nonprofit hospitals in 2019. But here's why the sector is still pretty stable.
Positive results from supervised injection sites abroad suggest it’s time for U.S. policymakers to consider piloting similar programs stateside.
The federal government brought in 30% less in fraud recoveries in 2018, but corporate integrity agreements could be serving as a deterrent.
Policymakers should take steps to ease pricing concerns in markets that are already concentrated instead of focusing just on future deals.